Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,193,418
+$670,798 QoQ
Shares Held
12,574
+21.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,959
of 4,664 holders
Holding Since
Mar 2020
21 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $17,885,890 across 12 Drug Manufacturers - General names. JNJ ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,508 | $4,405,712 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
12,574 | $3,193,418 | |
| 3 | LLY |
ELI LILLY & Co
|
2,498 | $2,996,175 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
17,214 | $2,174,816 | |
| 5 | AMGN |
Amgen Inc
|
5,256 | $1,903,301 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,663 | $1,627,195 | |
| 7 | PFE |
Pfizer Inc
|
51,109 | $1,230,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,625 | $208,872 |
All Filings in JNJ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,193,418 | 12,574 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,522,620 | 10,320 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,029,144 | 9,805 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,833,618 | 9,889 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,506,726 | 9,864 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,300,517 | 7,842 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $942,343 | 6,516 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,029,243 | 6,351 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $913,353 | 6,249 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,282,920 | 8,110 | Shares | Sole | 2024-05-09 | |
| 2022-09-30 | $1,063,310 | 6,509 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,774,389 | 9,996 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,152,703 | 6,504 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,112,126 | 6,501 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,592,874 | 9,863 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,085,142 | 6,587 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,082,244 | 6,585 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,035,875 | 6,582 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,026,974 | 6,898 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $969,784 | 6,896 | Shares | Sole | 2021-11-02 | |
| 2020-03-31 | $903,879 | 6,893 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||